Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity

Australia News News

Popularity of Ozempic, Mounjaro, similar drugs may be driving shortages for people with diabetes, obesity
Australia Latest News,Australia Headlines
  • 📰 ABC
  • ⏱ Reading Time:
  • 63 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 51%

Drugs such as Ozempic, Mounjaro and Wegovy have been touted as breakthrough drugs for patients looking to lose weight. But with the increased demand have come reports of access problems for diabetic patients with dire health issues.

Mounjaro injection pen on display in Carlsbad, Calif., Nov. 30, 2022.Drugs such as Ozempic, Mounjaro and Wegovy have been flying off pharmacy shelves across the country,for patients looking to lose weight. Celebrities like Rosie O'Donnell, Chelsea Handler, Millionaire Matchmaker star Patti Stanger and social media influencers claimed to have used the medications and credit them with changing their lives.

Ozempic and Mounjaro were approved by the FDA in 2017 and 2022, respectively, as treatments for Type 2 diabetes. They are not approved for weight loss but can be prescribed off-label by doctors. Wegovy, meanwhile, is FDA approved for obesity and diabetes.More than 40% of the U.S. population is obese, which puts tens of millions of Americans at risk of heart disease, stroke, Type 2 diabetes, certain types of cancers and even death, according to the U.S. Centers for Disease Control and Prevention.

Weinstein said the patients to whom she's prescribed the drugs, like Caley Svensson, have seen improvements in their weight and mental health. Pharmacies around the country said they don't have enough supply to meet demand, sending some patients into a panic. Shane Anthony, a 57-year-old diabetic, talks with"Impact x Nightline" about his struggles to find much needed diabetic medicine.Anthony's wife, Gerilyn Oenning, a nurse, expressed her frustrations with the situation in a viral social media post that blamed people who obtain the drugs but aren't obese or diabetic for the shortages.

Dr. Weinstein said it was not advisable to prescribe Ozempic and Mounjaro to patients who aren't obese.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC /  🏆 471. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Meghan McCain Claims She's Being Urged to Take Ozempic for Weight LossMeghan McCain Claims She's Being Urged to Take Ozempic for Weight Loss'I understand some people legitimately struggle with obesity and need Ozempic. But I am not one of those people.'
Read more »

Ozempic Runs Low for Diabetes Patients as Weight-Loss Use SurgesOzempic Runs Low for Diabetes Patients as Weight-Loss Use SurgesOzempic’s popularity among people looking to lose weight has limited supplies for diabetes patients who depend on the drug to control their blood sugar
Read more »

Diabetes drugs in short supply as they grow in popularity as weight-loss toolDiabetes drugs in short supply as they grow in popularity as weight-loss toolPrescriptions for a Type 2 diabetes drug, Ozempic, are rising exponentially as celebrities and high-profile figures publicize its usefulness for weight loss. ElonMusk is among those who have admitted to using the drug.
Read more »

Meghan Markle and Prince Harry's popularity hits all-time lowMeghan Markle and Prince Harry's popularity hits all-time lowThe slump in Harry and Meghan's popularity in the U.S. may not hit them in the pocket as they have been unpopular in Britain for years but their projects remain a commercial success.
Read more »

STAYC's 'Teddy Bear' steadily gaining popularity | allkpopSTAYC is one of the new 4th generation girl groups with high expectations, as the members are blessed with exceptional visuals, sin…
Read more »



Render Time: 2025-02-28 09:10:28